Prognostic Factors for Clinical Outcomes and Lesion Reactivation in Stage 2-3 Type 3 Macular Neovascularization Treated Using a Treat-and-Extend Regimen.

چکیده

To evaluate the treatment outcomes of type 3 macular neovascularization(MNV) and identify factors associated with visual outcomes and lesion reactivation during 76 weeks of aflibercept therapy using a treat-and-extend(TAE) regimen. This post hoc analysis included 25 treatment-naïve patients with…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• درمان های ضد VEGF
• شبکیه